Pnc Financial Services Group, Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 370 shares of MDGL stock, worth $123,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
370
Previous 375
1.33%
Holding current value
$123,354
Previous $105,000
25.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MDGL
# of Institutions
296Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$826 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$681 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$676 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$665 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$658 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.7B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...